Benefits of superficial hyperthermia treatment planning: five case studies
/in Breast Cancer, Hyperthermia, International Publications, Malignant Melanoma /von 2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
/in Hyperthermia, International Publications, Prostate Cancer /von 2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-6Dendritic cell vaccination
/in Breast Cancer, Colorectal Cancer, Hypernephroma, International Publications, Malignant Melanoma, Prostate Cancer /von 2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-33Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area
/in Cervical Cancer, International Publications /von 2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):443-50Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
/in HIV/AIDS, International Publications /von 2007-08-01 / Eur. J. Immunol. 2007 Aug;37(8):2164-73Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma
/in International Publications, Pancreatic Cancer /von 2007-07-24 / J. Natl. Cancer Inst. 2007 Aug;99(15):1188-99Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
/in Glioblastoma, International Publications /von 2007-07-20 / Immunology 2007 Dec;122(4):615-22Development of vaccines for high-risk ductal carcinoma in situ of the breast
/in Breast Cancer, International Publications /von 2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-4[State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus]
/in International Publications, Prostate Cancer /von 2007-07-01 / Bull Cancer 2007 Jul;94(7 Suppl):F69-76
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de